Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:11 AM
Ignite Modification Date:
2025-12-25 @ 12:11 AM
NCT ID:
NCT02330458
Eligibility Criteria:
Inclusion Criteria:
* Age 6-23 years
* Initiating Infliximab therapy
* Crohns disease involving the distal small bowel +/- proximal colon
* Willingness to undergo SBUS and fecal calprotectin collection prior to starting infliximab and again at week 14 and week 54
* Able to give consent by patient and/or legal guardian
Exclusion Criteria:
* Ulcerative colitis or non-Crohn's Disease patients
* Lack of small bowel disease
* Patients started on alternative therapy
* Unable or unwilling to provide consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
23 Years
Study:
NCT02330458
Study Brief:
Protocol Section:
NCT02330458